These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21771009)

  • 1. Proteinuria with fumaric acid ester treatment for psoriasis.
    Ogilvie S; Lewis Jones S; Dawe R; Foerster J
    Clin Exp Dermatol; 2011 Aug; 36(6):632-4. PubMed ID: 21771009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities.
    Balasubramaniam P; Stevenson O; Berth-Jones J
    Br J Dermatol; 2004 Apr; 150(4):741-6. PubMed ID: 15099371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study.
    Wain EM; Darling MI; Pleass RD; Barker JN; Smith CH
    Br J Dermatol; 2010 Feb; 162(2):427-34. PubMed ID: 19519838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal dysfunction in patients taking fumaric acid esters - a retrospective cross-sectional study.
    Menzies S; Ismail N; Abdalla A; Collins P; Kirby B; Holian J; Lally A
    J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):686-691. PubMed ID: 27790753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fumaric acid esters in the management of severe psoriasis.
    Brewer L; Rogers S
    Clin Exp Dermatol; 2007 May; 32(3):246-9. PubMed ID: 17362235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German Multicentre Study.
    Mrowietz U; Christophers E; Altmeyer P
    Br J Dermatol; 1998 Mar; 138(3):456-60. PubMed ID: 9580799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nail psoriasis improvement in a patient treated with fumaric acid esters.
    Vlachou C; Berth-Jones J
    J Dermatolog Treat; 2007; 18(3):175-7. PubMed ID: 17538807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis.
    Hoefnagel JJ; Thio HB; Willemze R; Bouwes Bavinck JN
    Br J Dermatol; 2003 Aug; 149(2):363-9. PubMed ID: 12932244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases.
    Harries MJ; Chalmers RJ; Griffiths CE
    Br J Dermatol; 2005 Sep; 153(3):549-51. PubMed ID: 16120141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunomodulation with fumaric acid. Systemic therapy in psoriasis].
    Sebók B; Schneider I
    Orv Hetil; 2000 Jan; 141(3):129-32. PubMed ID: 10693335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of an oral histamine antagonist to reduce adverse events associated with fumaric acid esters in the treatment of psoriasis: a randomized double-blind placebo-controlled trial.
    Balak DM; Fallah-Arani S; Venema CM; Neumann HA; Thio HB
    Br J Dermatol; 2015 Mar; 172(3):754-9. PubMed ID: 25041291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fumaric acid ester-induced T-cell lymphopenia in the real-life treatment of psoriasis.
    Dickel H; Bruckner T; Höxtermann S; Dickel B; Trinder E; Altmeyer P
    J Eur Acad Dermatol Venereol; 2019 May; 33(5):893-905. PubMed ID: 30680823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fumaric acid esters as a suitable first-line treatment for severe psoriasis: an Irish experience.
    Heelan K; Markham T
    Clin Exp Dermatol; 2012 Oct; 37(7):793-5. PubMed ID: 22548419
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness and safety of fumaric acid esters in children with psoriasis: a retrospective analysis of 14 patients from The Netherlands.
    Balak DM; Oostveen AM; Bousema MT; Venema AW; Arnold WP; Seyger MM; Thio HB
    Br J Dermatol; 2013 Jun; 168(6):1343-7. PubMed ID: 23738641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic treatment with fumaric acid esters in six paediatric patients with psoriasis in a psoriasis centre.
    Steinz K; Gerdes S; Domm S; Mrowietz U
    Dermatology; 2014; 229(3):199-204. PubMed ID: 25247273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fumaric acid esters, their place in the treatment of psoriasis.
    Ormerod AD; Mrowietz U
    Br J Dermatol; 2004 Apr; 150(4):630-2. PubMed ID: 15099356
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of fumaric acid esters in patients with psoriasis on medication for comorbid conditions - a retrospective evaluation (FACTS).
    Thaçi D; Weisenseel P; Philipp S; Rosenbach T; Rotterdam S; Augustin M; Neureither M; Reich K
    J Dtsch Dermatol Ges; 2013 May; 11(5):429-35. PubMed ID: 23433431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term real-life safety profile and effectiveness of fumaric acid esters in psoriasis patients: a single-centre, retrospective, observational study.
    Dickel H; Bruckner T; Altmeyer P
    J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1710-1727. PubMed ID: 29705996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant melanoma during treatment with fumaric acid esters - coincidence or treatment-related?
    Barth D; Simon JC; Wetzig T
    J Dtsch Dermatol Ges; 2011 Mar; 9(3):223-5. PubMed ID: 20678147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of fumaric acid esters in psoriasis.
    Roll A; Reich K; Boer A
    Indian J Dermatol Venereol Leprol; 2007; 73(2):133-7. PubMed ID: 17456929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.